
Management of HER2-Altered Non-Small Cell Lung Cancer
Oncology Today with Dr Neil Love
00:00
Trastuzumab in Breast Cancer - What's Your Vision?
Trastuzumab is naked antibody without the warhead. So it's a missile, but it doesn't have the bomb. What it does is it's got multiple mechanisms of action. It certainly has a signal inhibition capability. And that will localize the enemy with HER2 and then elicit these antibody responses that are cell-mediated.
Transcript
Play full episode